T. Rowe Price Associates’s Janux Therapeutics JANX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$41.4M Buy
2025
Q1
$37.6M Buy
2024
Q4
$59.4M Buy
2024
Q3
$7.24M Sell
2024
Q2
$10.6M Buy
2024
Q1
$739K Buy